ojrdrtОнкологический журнал: лучевая диагностика, лучевая терапияJournal of oncology: diagnostic radiology and radiotherapy2587-75932713-167XНЕКОММЕРЧЕСКОЕ ПАРТНЕРСТВО «ОБЩЕСТВО ИНТЕРВЕНЦИОННЫХ ОНКОРАДИОЛОГОВ»10.37174/2587-7593-2025-8-3-35-44ojrdrt-464Research ArticleЛУЧЕВАЯ ТЕРАПИЯRADIOTHERAPYРоль и место лучевой терапии в комплексном лечении больных первично-диссеминированным раком молочной железы. Обзор литературы и клинические наблюденияRole and Place of Radiation Therapy in Complex Treatment of Patients with de novo Metastatic Breast Cancer. Literature Review and Clinical Observationshttps://orcid.org/0000-0003-0504-1488ТимошкинаЕ. В.TimoshkinaE. V.

Тимошкина Екатерина Валерьевна, +79104040067 

115478 Москва, Каширское шоссе, 24 

Ekaterina V. Timoshkina, +79104040067 

24 Kashirskoe highway, Moscow 115478 

doctoretim@gmail.comhttps://orcid.org/0000-0002-7204-370XТрофимоваО. П.TrofimovaO. P.

115478 Москва, Каширское шоссе, 24 

125993 Москва, ул. Баррикадная, д. 2/1, стр. 1 

24 Kashirskoe highway, Moscow 115478 

2/1 b1, Barrikadnaya str., Moscow 125993

https://orcid.org/0000-0002-8062-570XГлебовскаяВ. В.GlebovskayaV. V.

111123 Москва, ш. Энтузиастов, 86

86 Enthusiasts sh., Moscow 111123

https://orcid.org/0000-0003-4944-4035ЧерныхМ. В.ChernykhM. V.

115478 Москва, Каширское шоссе, 24

24 Kashirskoe highway, Moscow 115478 

https://orcid.org/0000-0001-8965-8172ТкачевС. И.TkachevS. I.

115478 Москва, Каширское шоссе, 24 

24 Kashirskoe highway, Moscow 115478 

https://orcid.org/0000-0003-1958-7262ИвановС. М.IvanovS. M.

115478 Москва, Каширское шоссе, 24 

24 Kashirskoe highway, Moscow 115478 

Национальный медицинский исследовательский центp онкологии им. Н.Н. Блохина Минздрава РоссииРоссияN.N. Blokhin National Medical Research Center of OncologyRussian FederationНациональный медицинский исследовательский центp онкологии им. Н.Н. Блохина Минздрава России ; Российская медицинская академия непрерывного профессионального образования Минздрава РоссииРоссияN.N. Blokhin National Medical Research Center of Oncology ; Russian Medical Academy of Continuous Professional EducationRussian FederationМосковский клинический научный центр имени А.С. Логинова ДЗМРоссияA.S. Loginov Moscow Clinical Scientific CenterRussian Federation202523092025833544Copyright © Тимошкина Е.В., Трофимова О.П., Глебовская В.В., Черных М.В., Ткачев С.И., Иванов С.М., 20252025Тимошкина Е.В., Трофимова О.П., Глебовская В.В., Черных М.В., Ткачев С.И., Иванов С.М.Timoshkina E.V., Trofimova O.P., Glebovskaya V.V., Chernykh M.V., Tkachev S.I., Ivanov S.M.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.oncoradjournal.ru/jour/article/view/464

Согласно актуальным клиническим рекомендациям ведущим методом лечения при первично-диссеминированном раке молочной железы (ПДРМЖ) является лекарственная терапия. Однако в настоящее время активно изучается возможность и целесообразность проведения локальных методов лечения первичного очага у вышеуказанных пациенток, таких как хирургическое вмешательство и лучевая терапия. В статье представлен обзор данных современной литературы, связанных с вопросами проведения дистанционной лучевой терапии у больных ПДРМЖ, и собственные клинические наблюдения.

According to state-of-art clinical guidelines, the leading method of treatment for de novo metastatic breast cancer is systemic therapy. However, the possibility and feasibility of performing local methods in treating the primary lesion in the above mentioned patients, such as surgery and radiation therapy, is currently being actively studied. This article provides a review of modern literature data related to the issues of external beam radiation therapy in patients with de novo metastatic breast cancer and presents our own clinical observations.

первично-диссеминированный рак молочной железылучевая терапиярадикальный курсde novo primary breast cancerradiotherapyradical courseReferencesКлинические рекомендации по лечению рака молочной железы, 2021 г.Clinical guidelines for breast cancer treatment. 2021Breast cancer. NCCN guideline version 4.2025.Breast cancer. NCCN guideline version 4.2025.Rashid OM, Nagahash M, Ramachandran S, et al. Resection of the Primary Tumor Improves Survival in Metastatic Breast Cancer by Reduction of Overall Tumor Burden. Surgery. 2013;153(6):771-8. https://doi.org/10.1016/j.surg.2013.02.002.Rashid OM, Nagahash M, Ramachandran S, et al. Resection of the Primary Tumor Improves Survival in Metastatic Breast Cancer by Reduction of Overall Tumor Burden. Surgery. 2013;153(6):771-8. https://doi.org/10.1016/j.surg.2013.02.002.Liu H, Patel MR, Prescher JA, et al. Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models. Proc Nat Acad of the USA. 2010;107(42):18115-20. https://doi.org/10.1073/pnas.1006732107Liu H, Patel MR, Prescher JA, et al. Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models. Proc Nat Acad of the USA. 2010;107(42):18115-20. https://doi.org/10.1073/pnas.1006732107Fehm T, Sagalowsky A, Clifford E, et al. Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clinical Cancer Research. 2002;8(7):2073-84. https://doi.org/10.1073/pnas.1006732107.Fehm T, Sagalowsky A, Clifford E, et al. Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clinical Cancer Research. 2002;8(7):2073-84. https://doi.org/10.1073/pnas.1006732107.Pons-Tostivint E, Alouani E, Kirova Y, et al. Is there a role for locoregional treatment of the primary tumor in de novo metastatic breast cancer in the era of tailored therapies? Critical Reviews in Oncology/Hematology. 2021;157:103-6. https://doi.org/10.1016/j.critrevonc.2020.103146.Pons-Tostivint E, Alouani E, Kirova Y, et al. Is there a role for locoregional treatment of the primary tumor in de novo metastatic breast cancer in the era of tailored therapies? Critical Reviews in Oncology/Hematology. 2021;157:103-6. https://doi.org/10.1016/j.critrevonc.2020.103146.Soran A, Ozmen V, Ozbas S, et al. Randomized Trial Comparing Resection of Primary Tumor with No Surgery in Stage IV Breast Cancer at Presentation: Protocol MF07-01. Annals of Surgical Oncology. 2018;25(11):3141-9. https://doi.org/10.1245/s10434-018-6494-6Soran A, Ozmen V, Ozbas S, et al. Randomized Trial Comparing Resection of Primary Tumor with No Surgery in Stage IV Breast Cancer at Presentation: Protocol MF07-01. Annals of Surgical Oncology. 2018;25(11):3141-9. https://doi.org/10.1245/s10434-018-6494-6Khan SA, Stewart AK, Morrow M. Does aggressive local therapy improve survival in metastatic breast cancer? Surgery. 2002;132:620-7. https://doi.org/10.1067/msy.2002.127544.Khan SA, Stewart AK, Morrow M. Does aggressive local therapy improve survival in metastatic breast cancer? Surgery. 2002;132:620-7. https://doi.org/10.1067/msy.2002.127544.Божок АА, Топузов ЭЭ, Семиглазов ВФ и др. Возможности хирургического лечения при диссеминированном раке молочной железы. Вопросы онкологии. 2013;59(3);320-7. https://doi.org/10.37469/0507‑3758‑2013‑59‑3‑320‑327Bozhok АА, Topuzov EE, Semiglazov VF, et al. Possibilities of surgical treatment for disseminated breast cancer. Problems in Onkology. 2013;59(3):320-7. (In Russ.) https://doi.org/10.37469/0507‑3758‑2013‑59‑3‑320‑327Чернова ЕВ, Хайленко ВА, Артамонова ЕВ и др. Целесообразность удаления первичной опухоли у больных с впервые выявленным диссеминированным раком молочной железы. Российский онкологический журнал. 2013;(2):27-31. https://doi.org/10.17816/onco39969Chernova EV, Khaylenko VA, Artamonova EV, et al. Reasonability of the primary tumor removal in metastatic breast cancer patients at initial presentation. Russian Oncological Journal. 2013;(2):27-31. (in Russ.) https://doi.org/10.17816/onco39969Божок АА, Топузов ЭЭ, Зикиряходжаев АД и др. Оценка результатов НИР РООМ «Возможности хирургического лечения больных раком молочной железы IV стадии». Опухоли женской репродуктивной системы, 2016:4(12):17-24. https://doi.org/10.17650/1994-4098-2016-12-4-17-24Bozhok AA, Topuzov EE, Zikiryakhodzhaev AD, et al. Evaluation of the scientific results of the study entitled “Opportunities for surgical treatment of patients with stage IV breast cancer” performed by Russian Society of Oncomammologists (RSOM). Tumors of Female Reproductive System. 2016;12(4):17-24. (In Russ.). https://doi.org/10.17650/1994-4098-2016-12-4-17-24Blanchard DK, Shetty PB, Hilsenbeck S, et al. Association of surgery with improved survival in stage IV breast cancer patients. Annals of Surgery. 2008;247(5):732-8. https://doi.org/10.1097/SLA.0b013e3181656d32.Blanchard DK, Shetty PB, Hilsenbeck S, et al. Association of surgery with improved survival in stage IV breast cancer patients. Annals of Surgery. 2008;247(5):732-8. https://doi.org/10.1097/SLA.0b013e3181656d32.Babiera GV, Rao R, Feng L, et al. Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor. Annals of Surgical Oncology. 2006;13(6):776-82. https://doi.org/10.1245/ASO.2006.03.033.Babiera GV, Rao R, Feng L, et al. Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor. Annals of Surgical Oncology. 2006;13(6):776-82. https://doi.org/10.1245/ASO.2006.03.033.Lang JE, Tereffe W, Mitchell MP, et al. Primary tumor extirpation in breast cancer patients who present with stage IV disease is associated with improved survival. Annals of Surgical Oncology. 2013;20(6):1893-99. https://doi.org/10.1245/s10434-012-2844-y.Lang JE, Tereffe W, Mitchell MP, et al. Primary tumor extirpation in breast cancer patients who present with stage IV disease is associated with improved survival. Annals of Surgical Oncology. 2013;20(6):1893-99. https://doi.org/10.1245/s10434-012-2844-y.Rapiti E, Verkooijen HM, Vlastos G, et al. Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis. Journal of Clinical Oncology. 2006;24(18):2743-49. https://doi.org/10.1200/JCO.2005.04.2226.Rapiti E, Verkooijen HM, Vlastos G, et al. Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis. Journal of Clinical Oncology. 2006;24(18):2743-49. https://doi.org/10.1200/JCO.2005.04.2226.Reinhorn D, Mutai R, Yerushalmi R, et al. Locoregional therapy in de novo metastatic breast cancer: Systemic review and meta-analysis. Breast. 2021;58:173-81. https://doi.org/10.1016/j.breast.2021.05.003.Reinhorn D, Mutai R, Yerushalmi R, et al. Locoregional therapy in de novo metastatic breast cancer: Systemic review and meta-analysis. Breast. 2021;58:173-81. https://doi.org/10.1016/j.breast.2021.05.003.Pons-Tostivint E, Kirova Y, Lusque A, et al. Radiation therapy to the primary tumor for de novo metastatic breast cancer and overall survival in a retrospective multicenter cohort analysis. Radiotherapy & Oncology. 2020;145:109-16. https://doi.org/10.1016/j.radonc.2019.12.019.Pons-Tostivint E, Kirova Y, Lusque A, et al. Radiation therapy to the primary tumor for de novo metastatic breast cancer and overall survival in a retrospective multicenter cohort analysis. Radiotherapy & Oncology. 2020;145:109-16. https://doi.org/10.1016/j.radonc.2019.12.019.Kim BH, Kim S, Kim YI, et al. Development of an Individualized Prediction Calculator for the Benefit of Postoperative Radiotherapy in Patients with Surgically Resected De Novo Stage IV Breast Cancer. Cancers. 2020;12(8):2103. https://doi.org/10.3390/cancers12082103.Kim BH, Kim S, Kim YI, et al. Development of an Individualized Prediction Calculator for the Benefit of Postoperative Radiotherapy in Patients with Surgically Resected De Novo Stage IV Breast Cancer. Cancers. 2020;12(8):2103. https://doi.org/10.3390/cancers12082103.Блиганов ПИ, Иванов ВА, Черных МВ и др. Стереотаксическая лучевая терапия метастазов в головном мозге: эффективность и токсичность лечения. Хирургия и онкология. 2025;15(2):32-40. https://doi.org/10.17650/2949-5857-2025-15-2-32-40Bliganov PI, Ivanov VA, Chernykh MV et al. Stereotactic radiation therapy of brain metastases: efficacy and toxicity of treatment. Surgery and Oncology. 2025;15(2):32-40. (In Russ.). https://doi.org/10.17650/2949-5857-2025-15-2-32-40Bourgier C, Khodari W, Vataire AL, et al. Breast radiotherapy as part of loco-regional treatments in stage IV breast cancer patients with oligometastatic disease. Radiotherapy and Oncology. 2010:96:199-203. https://doi.org/10.1016/j.radonc.2010.02.028.Bourgier C, Khodari W, Vataire AL, et al. Breast radiotherapy as part of loco-regional treatments in stage IV breast cancer patients with oligometastatic disease. Radiotherapy and Oncology. 2010:96:199-203. https://doi.org/10.1016/j.radonc.2010.02.028.Le Scodan R, Stevens D, Brain E, et al. Breast cancer with synchronous metastases: survival impact of exclusive locoregional radiotherapy. Journal of Clinical Oncology. 2009;27:1375-81. https://doi.org/10.1200/JCO.2008.19.5396Le Scodan R, Stevens D, Brain E, et al. Breast cancer with synchronous metastases: survival impact of exclusive locoregional radiotherapy. Journal of Clinical Oncology. 2009;27:1375-81. https://doi.org/10.1200/JCO.2008.19.5396

The authors declare that there are no conflicts of interest present.